Perioperative Considerations of Kawasaki Disease

Overview

Journal Ochsner J

Specialty General Medicine

Date 2013 Jun 22

PMID 23789007

Citations 2

Authors

Lisa To

Stephen T Krazit

Alan D Kaye

Affiliations

Soon will be listed here.

Abstract

Background: Kawasaki disease (KD) is an acute febrile illness that primarily affects young children. Coronary arteritis is an important clinical feature of KD because it is associated with aneurysms and thromboembolic events that can lead to ischemic heart disease, sudden death, and congestive heart failure. KD involvement in multiple organ systems provides a potentially challenging dilemma for clinicians.

Methods: This review discusses the pathogenesis of the disease, including diagnosis, clinical features, and treatments. An additional focus is the development of strategies for the successful surgical management of patients with a KD history, emphasizing the preoperative assessment and the operative arena.

Conclusion: Although treatments for KD are largely standardized, patients with the disease who require surgical interventions must be properly assessed to determine the degree of pathogenesis, especially the extent of cardiac involvement.

Citing Articles

Kawasaki Disease and General Anesthesia for Dental Treatment: A Case Report.

Lee S, Guthrie D, Epstein R Anesth Prog. 2021; 68(3):146-153.

PMID: 34606572 PMC: 8500318. DOI: 10.2344/anpr-68-01-06.

Kawasaki disease and general anaesthesia: The Know - Hows.

Ponde V, Bedekar V, Manalang C Indian J Anaesth. 2018; 62(3):234-235.

PMID: 29643561 PMC: 5881329. DOI: 10.4103/ija.IJA_627_17.

References

Printz B, Sleeper L, Newburger J, Minich L, Bradley T, Cohen M . Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol. 2010; 57(1):86-92. PMC: 3577068. DOI: 10.1016/j.jacc.2010.08.619. View

Chang R . The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997. Pediatrics. 2003; 111(5 Pt 1):1124-5. DOI: 10.1542/peds.111.5.1124. View

Eberhard B, Sundel R, Newburger J, Baker A, Fuhlbrigge R, Burns J . Psoriatic eruption in Kawasaki disease. J Pediatr. 2000; 137(4):578-80. DOI: 10.1067/mpd.2000.107840. View

Kitamura S, Kameda Y, Seki T, Kawachi K, Endo M, Takeuchi Y . Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg. 1994; 107(3):663-73; discussion 673-4. View

Moran A, Newburger J, Sanders S, Parness I, Spevak P, Burns J . Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J. 2000; 139(2 Pt 1):217-23. DOI: 10.1067/mhj.2000.101221. View

Singh R, Ward C, Walton M, Persad R . Atypical Kawasaki disease and gastrointestinal manifestations. Paediatr Child Health. 2008; 12(3):235-7. PMC: 2528695. DOI: 10.1093/pch/12.3.235. View

Burns J, Wiggins Jr J, Toews W, Newburger J, Leung D, Wilson H . Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr. 1986; 109(5):759-63. DOI: 10.1016/s0022-3476(86)80689-8. View

Naoe S, Takahashi K, Masuda H, Tanaka N . Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn. 1991; 41(11):785-97. DOI: 10.1111/j.1440-1827.1991.tb01620.x. View

Terasawa K, Ichinose E, Matsuishi T, Kato H . Neurological complications in Kawasaki disease. Brain Dev. 1983; 5(4):371-4. DOI: 10.1016/s0387-7604(83)80041-2. View

10.

Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y . Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996; 94(6):1379-85. DOI: 10.1161/01.cir.94.6.1379. View

11.

Suda K, Matsumura M, Ohta S . Kawasaki disease complicated by cerebral infarction. Cardiol Young. 2003; 13(1):103-5. DOI: 10.1017/s1047951103000179. View

12.

Leung D . The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease. Acta Paediatr Jpn. 1991; 33(6):739-44. DOI: 10.1111/j.1442-200x.1991.tb02602.x. View

13.

Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T . Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation. 2000; 101(25):2935-41. DOI: 10.1161/01.cir.101.25.2935. View

14.

Carlton-Conway D, Ahluwalia R, Henry L, Michie C, Wood L, Tulloh R . Behaviour sequelae following acute Kawasaki disease. BMC Pediatr. 2005; 5(1):14. PMC: 1156909. DOI: 10.1186/1471-2431-5-14. View

15.

Holman R, Curns A, Belay E, Steiner C, Schonberger L . Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003; 112(3 Pt 1):495-501. DOI: 10.1542/peds.112.3.495. View

16.

Kanegaye J, Wilder M, Molkara D, Frazer J, Pancheri J, Tremoulet A . Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009; 123(5):e783-9. PMC: 2848476. DOI: 10.1542/peds.2008-1871. View

17.

Gallagher P . Facial nerve paralysis and Kawasaki disease. Rev Infect Dis. 1990; 12(3):403-5. DOI: 10.1093/clinids/12.3.403. View

18.

Newburger J, Takahashi M, Gerber M, Gewitz M, Tani L, Burns J . Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart.... Pediatrics. 2004; 114(6):1708-33. DOI: 10.1542/peds.2004-2182. View

19.

Kawasaki T . [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi. 1967; 16(3):178-222. View

20.

Magalhaes C, Magalhaes Alves N, Oliveira K, Silva I, Gandolfi L, Pratesi R . Sensorineural hearing loss: an underdiagnosed complication of Kawasaki disease. J Clin Rheumatol. 2010; 16(7):322-5. DOI: 10.1097/RHU.0b013e3181f603bc. View